Data link physical activity with reduced cancer-related fatigue in patients with colorectal cancer.
Andrea Eleazar, MHS
Advertisement
Andrea Eleazar, MHS, is an assistant editor for Targeted Oncology, with interests in noncommunicable diseases, health equity research, and global health. Eleazar holds a Master of Health Science in Epidemiology from the Johns Hopkins Bloomberg School of Public Health, as well as a BS in Public Health and certificate in Writing & Publishing from Drexel University.
Articles by Andrea Eleazar, MHS
The microbiota-based therapy MaaT013 showed promising efficacy and manageable safety in those with acute GVHD with gastrointestinal involvement.
Subcutaneous bispecific antibody cevostamab demonstrated early efficacy and safety in patients with relapsed or refractory multiple myeloma.
Durvalumab plus FLOT chemotherapy improved overall survival in resectable gastric or gastroesophageal junction cancer, per phase 3 MATTERHORN data.
Advertisement
Latest Updated Articles
Subcu Cevostamab Demonstrates Early Activity, Safety in R/R MyelomaPublished: December 8th 2025 | Updated:
Microbiota-Based Therapy Yields Response in Refractory GI-aGVHDPublished: January 2nd 2026 | Updated:
Advertisement
Advertisement
Trending on Oncology Nursing News
1
How Does Rina-S Work in Patients With Pretreated Endometrial Cancer?
2
World Cancer Day: What Does Cancer Look Like in 2026?
3
Multicancer Early Detection Testing: Promise and Challenges
4
Differentiating Denial From Coping Mechanisms in Oncology
5